Enpro NPO Food and pharmaceutical — Total third-party sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Enpro in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The official record: Enpro’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enpro's food and pharmaceutical — total third-party sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enpro's food and pharmaceutical — total third-party sales?
- Enpro (NPO) reported food and pharmaceutical — total third-party sales of $22.4M in Q1 2026.
- How has Enpro's food and pharmaceutical — total third-party sales changed year-over-year?
- Enpro's food and pharmaceutical — total third-party sales increased by 24.4% year-over-year, from $18M to $22.4M.
- What is the long-term trend for Enpro's food and pharmaceutical — total third-party sales?
- Over 3 years (2021 to 2024), Enpro's food and pharmaceutical — total third-party sales has grown at a 0.9% compound annual growth rate (CAGR), from $65.9M to $67.7M.
- What does food and pharmaceutical — total third-party sales mean?
- The total revenue earned from selling products to external customers within the food and pharmaceutical industry segment.
- How do you interpret food and pharmaceutical — total third-party sales?
- An increase indicates growing market share or higher demand for the company's specialized industrial solutions in the food and pharmaceutical sectors, while a decrease may signal market saturation or competitive pressure.
- How does food and pharmaceutical — total third-party sales compare across companies?
- Peers in the industrial components sector typically report this as a sub-segment revenue line, often compared against broader industrial manufacturing growth rates to gauge sector-specific performance.